Tag Archives: Blood pressure drug succeeds in mid-stage trial

Roche and partner Alnylam said on Tuesday their experimental drug against high blood pressure was shown to work when used in combination with the standard of care in a phase 2 trial. Full results of the Phase 2 KARDIA-2 trial, testing the twice-a-year injection zilebesiran, would be presented at the American College of Cardiology Annual Scientific Session in Atlanta on …

Read More »